Bayada Home Health Care, Inc. | |
7600 Central Avenue, 3rd Floor, Founders Building, Philadelphia, Pennsylvania 19111 | |
(215) 728-4200 | |
Name | Bayada Home Health Care, Inc. |
---|---|
Location | 7600 Central Avenue, 3rd Floor, Founders Building, Philadelphia, Pennsylvania |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 397231 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 19006, 19012, 19027, 19046, 19111, 19114, 19115, 19116, 19118, 19119, 19120, 19122, 19124, 19125, 19126, 19128, 19132, 19133, 19134, 19135, 19136, 19137, 19138, 19139, 19140, 19141, 19144, 19146, 19149, 19150, 19151, 19152, 19154 |
NPI Number | 1124069158 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 100 N 20th St Ste 200&203, Philadelphia, PA 19103 |
Phone Number | 215-413-5000 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1174842629 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 1315 Walnut St,, Suite 932, Philadelphia, PA 19107 |
Phone Number | 610-239-5955 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1326079807 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 100 N 20th St Ste 401, Philadelphia, PA 19103 |
Phone Number | 215-665-1147 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1639108541 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 1819 John F Kennedy Blvd Ste 424, Philadelphia, PA 19103 |
Phone Number | 215-568-6666 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1699092726 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Doing Business As | BAYADA PEDIATRICS |
Address | 100 N 20th St Ste 201, Philadelphia, PA 19103 |
Phone Number | 215-988-9006 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1760423883 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Doing Business As | BAYADA PEDIATRICS |
Address | 2133 Arch St, 4th Floor, Philadelphia, PA 19103 |
Phone Number | 267-443-2150 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1932120904 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 15 S 3rd St Fl 5, Philadelphia, PA 19106 |
Phone Number | 215-732-5050 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
NPI Number | 1952323966 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 100 N 20th St Ste 202, Philadelphia, PA 19103 |
Phone Number | 215-546-9231 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
Quality Rating: |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 94.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 86.4 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 69.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 69.2 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.5 | 96.4 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 81.9 | 79.6 |
How often patients got better at getting in and out of bed | 84.1 | 81.1 |
How often patients got better at bathing | 83.6 | 82.3 |
How often patients’ breathing improved | 75.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | 94.3 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 78.1 | 75 |
How often home health patients had to be admitted to the hospital | 17.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 93.1 | 94 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
The patient survey data of Bayada Home Health Care, Inc. is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 87 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 83 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 74 | 78 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A number of studies claim that artificial intelligence (AI) does as well or better than doctors at interpreting images and diagnosing medical conditions. However, a recent study published in The BMJ in March 2020 reveals that most of this research is flawed, and the results exaggerated. The outcome could be that the decision to adopt AI as part of patient care is based upon faulty premises, compromising the quality of patient care for millions of people.
A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
› Verified 6 days ago
Vna Of Greater Philadelphia Location: Falls Center, 3300 Henry Avenue, Suite 500, Philadelphia, Pennsylvania 19129 Ratings: Phone: (215) 473-0772 | |
Holy Redeemer Home Care-pa Location: 12265 Townsend Rd, Philadelphia, Pennsylvania 19154 Ratings: Phone: (215) 671-9200 | |
Homemaker Service Of The Metropolitan Area, Inc. Location: 444 North Third Street Ste 202, Philadelphia, Pennsylvania 19123 Ratings: NA Phone: (215) 592-0008 | |
Bayada Home Health Care, Inc. Location: 7600 Central Avenue, 3rd Floor, Founders Building, Philadelphia, Pennsylvania 19111 Ratings: Phone: (215) 728-4200 | |
Ken-care Home Health Agency Location: 6952 Germantown Avenue, 2nd Fl, Philadelphia, Pennsylvania 19119 Ratings: NA Phone: (215) 713-3880 | |